Biotech

All Articles

Metsera coordinate with Amneal to lock down GLP-1 supply

.Along with early stage 1 information today out in bush, metabolic disease attire Metsera is squande...

Rivus articles data to back up muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually introduced the information behind its own period 2 being overwei...

BMS pays $110M to create T-cell treatment treaty, aiding Top purchase opportunity to advance prioritized pipeline

.Bristol Myers Squibb is paying for Best Medication $110 thousand upfront to cultivate reagents for ...

Generate gains yet another $1B-plus Significant Pharma relationship

.Novartis has actually printer inked a package possibly worth greater than $1 billion with Flagship-...

Metsera GLP-1 data slice reveals 7.5% fat loss at 36 days

.Recently debuted Metsera is unfolding some stage 1 information for its GLP-1 receptor agonist, disc...

Flagship hopes biotechs flock to Mirai to improve hereditary medications

.Surrounded by the hereditary medications arms nationality, Crown jewel Pioneering is unveiling a br...

BioAge eyes $180M coming from IPO, personal positioning for excessive weight tests

.BioAge Labs is actually looking at about $180 million in initial earnings coming from an IPO and al...

Merck's LAG-3 combination falls short colon cancer phase 3 research study

.An effort through Merck &amp Co. to open the microsatellite secure (MSS) metastatic colorectal canc...

Spanish VC finalizes $200M lifestyle sciences fund

.Spain-based Asabys Partners has shut a fund of 180 million europeans ($ 200 thousand), money that i...

BioAge introduces $198M coming from IPO as being overweight biotech participates in Nasdaq

.BioAge Labs is actually generating nearly $200 thousand using its own Nasdaq IPO today, with the pr...